Lentine KL, et al. OPTN/SRTR 2020 Annual Data Report: Kidney. Am J Transplant 2022; 22 (Suppl 2):21–136. doi: 10.1111/ajt.16982

• PubMed
Lentine KL, OPTN/SRTR 2020 Annual Data Report: Kidney. Am J Transplant 2022; 22 (Suppl 2):21–136. doi: 10.1111/ajt.16982)| false
• Search Google Scholar
• Export Citation

Burton JR Jr, et al. Liver and kidney recipient selection of hepatitis C virus viremic donors: Meeting consensus report from the 2019 controversies in transplantation. Transplantation 2020; 104:476–481. doi: 10.1097/TP.0000000000003014

• PubMed
Burton JR Jr, Liver and kidney recipient selection of hepatitis C virus viremic donors: Meeting consensus report from the 2019 controversies in transplantation. Transplantation 2020; 104:476–481. doi: 10.1097/TP.0000000000003014)| false
• Search Google Scholar
• Export Citation

Querard A-H, et al. Comparison of survival outcomes between expanded criteria donor and standard criteria donor kidney transplant recipients: A systematic review and meta-analysis. Transpl Int 2016; 29:403–415. doi: 10.1111/tri.12736

• PubMed
Querard A-H, Comparison of survival outcomes between expanded criteria donor and standard criteria donor kidney transplant recipients: A systematic review and meta-analysis. Transpl Int 2016; 29:403–415. doi: 10.1111/tri.12736)| false
• Search Google Scholar
• Export Citation

Reese PP, et al. Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: A single-group trial. Ann Intern Med 2018; 169:273–281. doi: 10.7326/M18-0749

• PubMed
Reese PP, Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: A single-group trial. Ann Intern Med 2018; 169:273–281. doi: 10.7326/M18-0749)| false
• Search Google Scholar
• Export Citation

Durand CM, et al. Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: An open-label nonrandomized trial. Ann Intern Med 2018; 168:533–540. doi: 10.7326/M17-2871

• PubMed
Durand CM, Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: An open-label nonrandomized trial. Ann Intern Med 2018; 168:533–540. doi: 10.7326/M17-2871)| false
• Search Google Scholar
• Export Citation

Nguyen VH, et al. Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States. JAMA Netw Open 2022; 5:e2245424. doi: 10.1001/jamanetworkopen.2022.45424

• PubMed
Nguyen VH, Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States. JAMA Netw Open 2022; 5:e2245424. doi: 10.1001/jamanetworkopen.2022.45424)| false
• Search Google Scholar
• Export Citation

Durand CM, et al. The drug overdose epidemic and deceased-donor transplantation in the United States: A national registry study. Ann Intern Med 2018; 168:702–711. doi: 10.7326/M17-2451

• PubMed
Durand CM, The drug overdose epidemic and deceased-donor transplantation in the United States: A national registry study. Ann Intern Med 2018; 168:702–711. doi: 10.7326/M17-2451)| false
• Search Google Scholar
• Export Citation

Levitsky J, et al. The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. Am J Transplant 2017; 17:2790–2802. doi: 10.1111/ajt.14381

• PubMed
Levitsky J, The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. Am J Transplant 2017; 17:2790–2802. doi: 10.1111/ajt.14381)| false
• Search Google Scholar
• Export Citation

Gordon CE, et al. Kidney transplantation from hepatitis C virus-infected donors to uninfected recipients: A systematic review for the KDIGO 2022 hepatitis C clinical practice guideline update. Am J Kidney Dis (published online ahead of print April 14, 2023). doi: 10.1053/j.ajkd.2022.12.019; https://www.ajkd.org/article/S0272-6386(23)00592-9/fulltext

• PubMed
Gordon CE, Kidney transplantation from hepatitis C virus-infected donors to uninfected recipients: A systematic review for the KDIGO 2022 hepatitis C clinical practice guideline update. Am J Kidney Dis (published online ahead of print April 14, 2023). doi: 10.1053/j.ajkd.2022.12.019; https://www.ajkd.org/article/S0272-6386(23)00592-9/fulltext)| false
• Search Google Scholar
• Export Citation

Martin P, et al. Executive summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int 2022; 102:1228–1237. doi: 10.1016/j.kint.2022.07.012

• PubMed
Martin P, Executive summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int 2022; 102:1228–1237. doi: 10.1016/j.kint.2022.07.012)| false
• Search Google Scholar
• Export Citation

Henry B. Drug pricing & challenges to hepatitis C treatment access. J Health Biomed Law 2018; 14:265–283. PMID: 30258323

• PubMed
Henry B. Drug pricing & challenges to hepatitis C treatment access. J Health Biomed Law 2018; 14:265–283. PMID: 30258323)| false
• Search Google Scholar
• Export Citation